THERINI BIO, INC.

Profile

Company Names

THERINI BIO, INC.
MEDARED, INC.

Addresses

2108 N STREET, SUITE 4963, SACRAMENTO, CA 95816

2108 N ST., STE 4963, SACRAMENTO, CA 95816

681 GATEWAY BLVD., SUITE 411, SOUTH SAN FRANCISCO, CA 94080

1650 OWENS ST, ROOM 259, SAN FRANCISCO, CA 94158

Phone Numbers

858-414-1105
(818) 414-1105
6507937447
415-683-7399

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$84,226,899.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2023-03-29 
$74,870,150.00 
$80,781,009.00 
$5,910,859.00 
Equity, Debt 
1
2019-05-08 
$9,356,749.00 
$9,356,749.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
AIKATERINI 
 
AKASOGLOU 
DIRECTOR
MEDARED, INC.   |  THERINI BIO, INC.
HOUMAN 
 
ASHRAFIAN 
DIRECTOR
SV LIFE SCIENCES FUND IV CF, L.P.   |  DEMENTIA DISCOVERY FUND 2 LP   |  SV BIOTECH CROSSOVER OPPORTUNITIES FUND LP   |  THERINI BIO, INC.
LAURENCE 
 
BARKER 
DIRECTOR
DEMENTIA DISCOVERY LP   |  THERINI BIO, INC.   |  DEMENTIA DISCOVERY FUND 2 LP   |  ENDLYZ THERAPEUTICS, INC.
DANIEL 
 
BURGESS 
EXECUTIVE OFFICER, DIRECTOR
ARSANIS, INC.   |  ATOX BIO INC.   |  NABRIVA THERAPEUTICS PLC   |  QPEX BIOPHARMA, INC.   |  THERINI BIO, INC.   |  ARBUTUS BIOPHARMA CORP
DANIEL 
D 
BURGESS 
DIRECTOR
CIDARA THERAPEUTICS, INC.   |  THERINI BIO, INC.
LAIA 
 
CRESPO-MARTIN 
DIRECTOR
QURALIS CORP   |  THERINI BIO, INC.
OLGA 
 
DANILCHANKA 
DIRECTOR
THERINI BIO, INC.
DAVID 
 
DOLBY 
DIRECTOR
THERINI BIO, INC.
TARA 
 
NICKERSON 
EXECUTIVE OFFICER, DIRECTOR
THERINI BIO, INC.
MICHAEL 
 
QUIGLEY 
EXECUTIVE OFFICER, DIRECTOR
AXIOM-LONDON, LLC   |  AUGMENTED REALITY CONCEPTS, INC.   |  THERINI BIO, INC.
MICHAEL 
 
ROSS 
DIRECTOR
CERVILENZ INC   |  JUVARIS BIO THERAPEUTICS INC   |  IKANO THERAPEUTICS INC.   |  ADIMAB, INC.   |  SV LIFE SCIENCES FUND V LP   |  LINK MEDICINE CORP   |  CATABASIS PHARMACEUTICALS INC   |  SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.   |  ARSANIS, INC.   |  BALANCE HEALTH CORP   |  ABCAM PLC   |  ADIMAB, LLC   |  AVITIDE, INC.   |  OPHTHOTECH CORP.   |  THESAN PHARMACEUTICALS, INC.   |  SV LIFE SCIENCES FUND VI, L.P.   |  DECIPHERA PHARMACEUTICALS, LLC   |  DEMENTIA DISCOVERY LP   |  AMERICLEAN HOLDINGS LLC   |  SV LIFE SCIENCES FUND VI STRATEGIC PARTNERS, L.P.   |  FRESCO FOODS, INC.   |  SUTRO BIOPHARMA INC   |  RIBOMETRIX, INC.   |  JASON RYAN   |  NICE RECOVERY SYSTEMS LLC   |  THERINI BIO, INC.   |  MAINE CRISP COMPANY, LLC   |  JOSEPH VENTURES ALLIUM I LLC, SERIES A   |  XILIO THERAPEUTICS, INC.   |  JOSEPH VENTURES ALLIUM I LLC, SERIES C   |  SV LIFE SCIENCES FUND IV CF, L.P.   |  ANDOVIA INC.   |  TREX HOLDINGS INC.   |  DUALITAS THERAPEUTICS, INC.
TRACY 
 
SAXTON 
DIRECTOR
PANOPTICA, INC.   |  SUTROVAX, INC.   |  LUMOS PHARMA, INC.   |  ITERUM THERAPEUTICS LTD   |  THERINI BIO, INC.   |  RESERVOIR NEUROSCIENCE, INC.   |  MINDIMMUNE THERAPEUTICS, INC.
LESLIE 
 
SCHULZE 
EXECUTIVE OFFICER
THERINI BIO, INC.
EDWARD 
 
SPACK 
EXECUTIVE OFFICER
MEDARED, INC.
JEFFREY 
 
STAVENHAGEN 
EXECUTIVE OFFICER
THERINI BIO, INC.
JEFFREY 
 
STAVENHAGEN, PH.D. 
EXECUTIVE OFFICER
THERINI BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-03-29 
2023-04-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2023-03-29 
2020-05-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-08 
2019-05-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#